Schneiderman H, Hager W D, Gondos B
Ann Clin Lab Sci. 1986 Mar-Apr;16(2):134-45.
Endomyocardial biopsy (EMB) provides a safe, simple method of gathering unique information. Although the role of EMB continues to evolve rapidly, present consensus includes the following indications, based on the ability of EMB to provide diagnoses unobtainable by other means: assessment of early rejection following cardiac transplantation; determination of myocarditis as etiology of clinically obscure cardiac dysfunction; quantification of chemotherapeutic (especially anthracycline) cardiotoxicity; and distinction between constrictive and restrictive heart disease. Each of these indications carries major therapeutic as well as prognostic implications. Methods of processing EMB are presented, complications listed, artifacts described, findings and uses illustrated, and suggestions for future development addressed briefly.
心内膜心肌活检（EMB）提供了一种安全、简单的获取独特信息的方法。尽管EMB的作用仍在迅速演变，但基于EMB能够提供其他方法无法获得的诊断结果，目前的共识包括以下适应症：评估心脏移植后的早期排斥反应；确定心肌炎是临床隐匿性心脏功能障碍的病因；量化化疗（尤其是蒽环类药物）的心脏毒性；以及区分缩窄性和限制性心脏病。这些适应症中的每一个都具有重要的治疗和预后意义。文中介绍了EMB的处理方法，列出了并发症，描述了伪像，举例说明了检查结果和用途，并简要讨论了未来发展的建议。
